Medical Equipment Companies By Enterprise Value
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Current Valuation
| Current Valuation | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | EW | Edwards Lifesciences Corp | 0.08 | 1.77 | 0.15 | ||
| 2 | DXCM | DexCom Inc | 0.15 | 2.11 | 0.31 | ||
| 3 | MMSI | Merit Medical Systems | 0.05 | 1.30 | 0.06 | ||
| 4 | NARI | Inari Medical | 0.17 | 5.09 | 0.85 | ||
| 5 | NVST | Envista Holdings Corp | 0.06 | 2.30 | 0.13 | ||
| 6 | WRBY | Warby Parker | 0.08 | 2.71 | 0.21 | ||
| 7 | EMBC | Embecta Corp | 0.06 | 4.65 | 0.27 | ||
| 8 | NVCR | Novocure | 0.10 | 7.20 | 0.72 | ||
| 9 | ESTA | Establishment Labs Holdings | 0.02 | 5.20 | 0.08 | ||
| 10 | MDXG | MiMedx Group | (0.08) | 1.81 | (0.14) | ||
| 11 | BBNX | Beta Bionics, Common | (0.29) | 2.04 | (0.60) | ||
| 12 | OFIX | Orthofix Medical | 0.00 | 1.37 | 0.00 | ||
| 13 | CBLL | CeriBell, | (0.06) | 3.56 | (0.23) | ||
| 14 | NPCE | Neuropace | 0.15 | 3.78 | 0.55 | ||
| 15 | NYXH | Nyxoah | 0.15 | 3.07 | 0.47 | ||
| 16 | NNOX | Nano X Imaging | 0.07 | 6.74 | 0.48 | ||
| 17 | AVR | Anteris Technologies Global | 0.20 | 3.62 | 0.71 | ||
| 18 | ELMD | Electromed | 0.08 | 3.48 | 0.28 | ||
| 19 | BDMD | Baird Medical Investment | 0.12 | 81.48 | 9.75 | ||
| 20 | NVRO | Nevro Corp | 0.12 | 5.11 | 0.61 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents. Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.